5qHZ6pi1Eho https://histock.tw/talk/live.aspx?name=gtalk&id=1327 20250507 阿布波

台股 » 個股 » 英濟 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

英濟

(3294)
可現股當沖
  • 股價
    26.40
  • 漲跌
    ▼0.40
  • 漲幅
    -1.49%
  • 成交量
    382
  • 產業
    上櫃 電子零組件類股
  • 102人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
英濟 (3294)籌碼相關-統一-嘉義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1404/0104/1404/2405/0602/2603/1003/2005/08202530354045Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

統一-嘉義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/0500.00426.2526.40-43,565-0.11%
2025/04/2900.00228.0028.20-23,874-0.05%
2025/04/2800.00127.7027.90-14,060-0.02%
2025/04/251127.981027.6527.9014,6030.02%
2025/04/1700.00126.4026.50-16,254-0.02%
2025/04/08224.9500.0024.9527,6150.03%
2025/04/021030.7400.0030.75107,6470.13%
2025/03/18138.3000.0038.0517,6200.01%
2025/03/07137.4000.0036.3017,4760.01%
2025/03/03137.2500.0037.0017,3890.01%
2025/02/25138.7000.0038.8017,1770.01%
2025/02/24138.40139.0039.0007,1370.00%
2025/02/20140.90140.5540.3506,9960.00%
2025/02/1700.00240.0041.05-26,518-0.03%
2025/02/14142.80140.9540.6006,4550.00%
2025/02/13140.05640.5541.00-56,159-0.08%
2025/02/12540.45141.2040.4546,0400.07%
2025/02/11139.00138.6538.3005,7130.00%
2025/02/10441.3300.0040.3045,6250.07%
2025/02/07140.60640.7740.20-55,401-0.09%
2025/02/06540.95140.1040.9545,1040.08%
2025/02/05137.501.137.3237.25-0.14,9510.00%
2025/02/04236.80138.2037.5514,9010.02%
2025/01/22239.85539.2539.20-34,767-0.06%
2025/01/20440.88440.9540.7004,2900.00%
2025/01/171040.81540.9040.1053,7400.13%
2025/01/1600.000.439.4039.40-0.42,834-0.01%
2025/01/1500.00535.8735.85-52,632-0.19%
2025/01/13135.55134.0033.2002,3590.00%
2025/01/10836.45334.4035.0052,2010.23%
2025/01/0900.001437.9936.40-142,043-0.68%
2025/01/07536.0000.0036.0051,5670.32%
2025/01/02133.6000.0032.5019010.11%
2024/12/3100.00332.0533.75-3818-0.37%
2024/12/25530.31130.0530.3546010.66%
2024/12/09128.7000.0028.8517680.13%
2024/11/21129.3000.0029.7011,3620.07%
2024/11/1200.00328.4528.40-31,425-0.21%
2024/10/25131.65131.5031.5001,5870.00%
2024/10/24332.2300.0031.7531,6330.18%
2024/10/23132.50132.4032.4001,6610.00%
2024/10/18331.28031.4031.0031,8080.17%
2024/10/1700.001431.3431.40-141,961-0.71%
2024/10/1600.00231.0031.00-22,350-0.09%
2024/10/08633.0300.0033.2062,7450.22%
2024/10/0100.00131.4531.20-12,733-0.04%
2024/09/2700.00531.7031.85-52,759-0.18%
2024/09/2300.00032.2032.0002,7630.00%
2024/09/11333.7300.0033.1032,8180.11%
2024/09/10034.10334.0233.85-32,777-0.11%
2024/09/06232.40331.7531.90-12,664-0.04%
2024/09/0500.00232.8032.85-22,647-0.08%
2024/09/041031.0800.0030.90102,6180.38%
2024/09/02334.1700.0033.9032,6070.12%
2024/08/3016234.3315934.1133.5532,5240.12% 大買/大賣/
2024/08/2900.001031.6531.40-102,397-0.42%
2024/08/161030.5900.0030.45102,5720.39%
2024/08/08129.7000.0029.4012,8540.04%
2024/08/060.127.0500.0026.900.12,8770.00%
2024/07/290.134.5000.0031.200.12,9130.00%
2024/07/26133.90134.0534.0002,8870.00%
2024/07/2300.00336.0035.80-32,876-0.10%
2024/07/22437.29337.1536.5512,8690.03%
2024/07/19540.0800.0038.9552,8470.18%
2024/07/17443.563.542.9543.700.52,6810.02%
2024/07/1600.00939.6941.80-92,348-0.38%
2024/07/15437.9300.0038.0042,1980.18%
2024/07/1200.001236.8336.70-122,130-0.56%
2024/07/1000.00136.0536.35-12,283-0.04%
2024/07/09135.40834.9835.10-72,445-0.29%
2024/07/0400.00135.8035.80-13,092-0.03%
2024/07/0300.00136.0035.85-13,425-0.03%
2024/06/27935.4400.0035.2593,7890.24%
2024/06/21136.7500.0036.7514,2270.02%
2024/06/18137.4000.0037.5014,7830.02%
2024/06/130.135.3000.0035.400.15,3360.00%
2024/06/05137.2000.0036.9515,9830.02%
2024/06/0400.00437.9537.75-46,133-0.07%
2024/06/03439.90739.1739.00-36,481-0.05%
2024/05/30237.5000.0037.3026,4480.03%
2024/05/2900.00538.4538.95-56,475-0.08%
2024/05/28538.90139.1038.4546,4450.06%
2024/05/21238.1000.0038.0026,3740.03%
2024/05/20241.802041.8037.60-186,356-0.28%
2024/05/176038.004038.0838.55206,2290.32%
2024/05/100.134.7500.0035.800.16,5760.00%
〈焦點股〉益得攜英濟開發複方吸入劑 逆勢攻上漲停Anue鉅亨-2023/04/25
英濟拿下益得複方吸入劑給藥設備訂單 生醫事業添動能Anue鉅亨-2023/04/24
英濟 相關文章